Education
About Us
Working with TipRanks
Follow Us
Cooper Co (COO)
NASDAQ:COO
Earnings Data
Report Date
Aug 27, 2025TBA Not Confirmed
Period Ending
2025 (Q3)Consensus EPS Forecast
1.07Last Year’s EPS
0.96Same Quarter Last Year
Moderate Buy
Based on 13 Analysts Ratings
Earnings Call Summary
Earnings Call Date:May 29, 2025
|% Change Since: -9.99%
|Next Earnings Date:Aug 27, 2025
Earnings Call Sentiment|Neutral
The earnings call highlighted strong revenue and earnings growth, driven by robust performance in key segments like office and surgical, and myopia management. However, challenges such as fertility market softness, reduced market growth assumptions, and tariff impacts were also noted. While the highlights are significant, the lowlights point to underlying market challenges.Company Guidance
During the Q2 2025 earnings call for The Cooper Companies, Al White, the President and CEO announced a consolidated organic revenue growth of 7%, with total revenues reaching $1,002 million, a 6% increase year-over-year. CooperVision's revenues were $670 million, up 5% or 7% organically, while CooperSurgical's revenues were $333 million, an 8% increase. The company reported a 14% increase in non-GAAP earnings, with earnings per share at $0.96. The revenue guidance for fiscal 2025 was adjusted to a range of $4,110 million to $4,150 million, reflecting a 5.5% to 6.5% increase or 5% to 6% organically. Al White emphasized the strong performance of daily silicone hydrogel lenses, particularly MyDay, which grew by 10%, and the promising growth of the Myopia management portfolio, which rose by 19%, with MiSight up 35%. The effective tax rate was 14.6%, and free cash flow was $18 million, with capital expenditures of $78 million. The company also updated its non-GAAP EPS guidance to a range of $4.05 to $4.11, indicating a 10% to 11.5% growth.Strong Revenue Growth
Consolidated revenues were $1,002,000,000, up 6% year over year or up 7% organically. CooperVision revenues were $670,000,000, up 5% or 7% organically, and CooperSurgical revenues were $333,000,000, up 8% or 7% organically.
Non-GAAP Earnings Increase
Non-GAAP earnings were $0.96, up 14% year over year, driven by operational improvements and OpEx leverage.
Myopia Management Growth
Myopia management portfolio grew 19% with MiSight up 35%, supported by a new pricing model and increased fitting activity.
Office and Surgical Segment Performance
Office and Surgical sales were $206,000,000, up 13% or 10% organically, driven by minimally invasive gynecological surgical devices and labor and delivery products.
PARAGARD Growth
PARAGARD grew 18% this quarter, driven by channel fill before a price increase and continued interest in the new single hand inserter.
COO Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
COO Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 29, 2025 | $79.96 | $68.28 | -14.61% |
Mar 06, 2025 | $90.98 | $85.00 | -6.57% |
Dec 05, 2024 | $103.23 | $98.70 | -4.39% |
Aug 28, 2024 | $94.54 | $105.73 | +11.84% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Cooper Co (COO) report earnings?
Cooper Co (COO) is schdueled to report earning on Aug 27, 2025, TBA Not Confirmed.
What is Cooper Co (COO) earnings time?
Cooper Co (COO) earnings time is at Aug 27, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is COO EPS forecast?
COO EPS forecast for the fiscal quarter 2025 (Q3) is 1.07.
